Crucell and DSM Announce PER.C6(R) Licensing and Service Agreement with Roche for Protein Production
16 févr. 2005 02h13 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they...
Crucell Receives Patents Covering PER.C6(R) for Protein Production
16 févr. 2005 02h11 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted two pivotal patents relating to...
Crucell Confirms Selection for Amsterdam Midkap Index on Euronext
31 janv. 2005 08h05 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 31, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) announced today that its inclusion in the Amsterdam Midkap (AMX) index...
Crucell Fully Compliant
26 janv. 2005 07h38 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 26, 2005 (PRIMEZONE) -- In media coverage today a suggestion was made that insider trading occurred on the exercise of options on January 18, 2005, by certain employees...
Crucell Announces 2004 Annual Results
24 janv. 2005 09h01 HE
|
Crucell N.V.
LEIDEN, Netherlands, Jan. 24, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Nasdaq:CRXL) (Euronext:CRXL) today announced its 2004 financial results. Revenue for the year ended...
Boehringer Ingelheim Licenses Results from Target Discovery Collaboration with Galapagos
20 janv. 2005 02h08 HE
|
Crucell N.V.
LEIDEN, The Netherlands and MECHELEN, Belgium, Jan. 20, 2005 (PRIMEZONE) --Galapagos announced today that Boehringer Ingelheim has successfully used Galapagos' SilenceSelect(tm) gene knock-down...
Crucell Joins Influenza Vaccine Supply (IVS) International Task Force
14 janv. 2005 02h08 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 14, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been accepted as a new member of the Influenza...
Crucell to Release 2004 Earnings on Monday, January 24, 2005
10 janv. 2005 08h08 HE
|
Crucell N.V.
LEIDEN, Netherlands, Jan. 10, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced that it will release its full year 2004 financial results on...
Crucell Announces Evaluation by Genentech of STAR(TM) Technology
07 janv. 2005 02h08 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 7, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Genentech, Inc. (NYSE:DNA) is currently evaluating...
Crucell Receives European Patent Covering PER.C6(R) for Vaccine Production
05 janv. 2005 02h07 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Jan. 5, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted a patent by the European Patent...